TrialThe Lancet. Infectious diseases2014

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study.

Jorge E Osorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.